OX 1 orexin/hypocretin receptor activation of phospholipase D

British Journal of Pharmacology

Volumn 165, Issue 4 B, 2012, Pages 1109-1123

  Jantti M H ^a   Putula, J ^a   Somerharju, P ^b   Frohman, M A ^c   Kukkonen, J P ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c STONY BROOK UNIVERSITY   (United States)

^d MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

orexin; OX 1 receptor; PKC; PKD; PLD; Rho

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ARACHIDONIC ACID; CHLOROFORM; COMPLEMENTARY DNA; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; ISOENZYME; METHANOL; OLEIC ACID; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PHOSPHATIDIC ACID; PHOSPHOLIPASE D; PROTEIN KINASE C; RAC PROTEIN; RHO FACTOR; RHO KINASE; 1 (2 METHYLBENZOXAZOL 6 YL) 3 (1,5)NAPHTHYRIDIN 4 YL UREA; 1-(2-METHYLBENZOXAZOL-6-YL)-3-(1,5)NAPHTHYRIDIN-4-YL UREA; ACETOPHENONE DERIVATIVE; BENZOPYRAN DERIVATIVE; BENZOXAZOLE DERIVATIVE; DRUG DERIVATIVE; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; OREXIN RECEPTORS; OREXINS; PROTEIN KINASE C DELTA; PROTEIN KINASE INHIBITOR; ROTTLERIN; SIGNAL PEPTIDE; UREA;

ANION EXCHANGE CHROMATOGRAPHY; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; CRICETULUS; DRUG ANTAGONISM; HAMSTER; METABOLISM;

ACETOPHENONES; ANIMALS; BENZOPYRANS; BENZOXAZOLES; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; PHOSPHOLIPASE D; PROTEIN KINASE C-DELTA; PROTEIN KINASE INHIBITORS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; TETRADECANOYLPHORBOL ACETATE; UREA;

EID: 84856350405     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01565.x     Document Type: Review

References (77)

1. Aittaleb M, Boguth CA, Tesmer JJ, (2010). Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors. Mol Pharmacol 77: 111-125.
2. Alexander SP, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
3. Ammoun S, Holmqvist T, Shariatmadari R, Oonk HB, Detheux M, Parmentier M, et al,. (2003). Distinct recognition of OX1 and OX2 receptors by orexin peptides. J Pharmacol Exp Ther 305: 507-514. (Pubitemid 36459164)
4. Ammoun S, Johansson L, Ekholm ME, Holmqvist T, Danis AS, Korhonen L, et al,. (2006a). OX1 orexin receptors activate extracellular signal-regulated kinase (ERK) in CHO cells via multiple mechanisms: the role of Ca2+ influx in OX1 receptor signaling. Mol Endocrinol 20: 80-99. (Pubitemid 43011672)
5. Ammoun S, Lindholm D, Wootz H, Åkerman KE, Kukkonen JP, (2006b). G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress- activated protein kinase. J Biol Chem 281: 834-842.
6. Arrigoni E, Mochizuki T, Scammell TE, (2010). Activation of the basal forebrain by the orexin/hypocretin neurones. Acta Physiol (Oxf) 198: 223-235.
7. van den Bout I, Divecha N, (2009). PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions. J Cell Sci 122: 3837-3850.
8. Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, et al,. (2005). Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA 102: 19168-19173. (Pubitemid 43049584)
9. Brindley DN, Pilquil C, (2009). Lipid phosphate phosphatases and signaling. J Lipid Res 50: S225-S230.
10. Carrasco S, Merida I, (2007). Diacylglycerol, when simplicity becomes complex. Trends Biochem Sci 32: 27-36. (Pubitemid 46038735)
11. Chen J, Lu G, Wang QJ, (2005). Protein kinase C-independent effects of protein kinase D3 in glucose transport in L6 myotubes. Mol Pharmacol 67: 152-162. (Pubitemid 40069975)
12. Cho W, Stahelin RV, (2006). Membrane binding and subcellular targeting of C2 domains. Biochim Biophys Acta 1761: 838-849. (Pubitemid 44332329)
13. Churchill EN, Qvit N, Mochly-Rosen D, (2009). Rationally designed peptide regulators of protein kinase C. Trends Endocrinol Metab 20: 25-33.
14. Cid-Pellitero ED, Garzon M, (2011). Hypocretin1/OrexinA axon targeting of laterodorsal tegmental nucleus neurons projecting to the rat medial prefrontal cortex. Cereb Cortex doi: 10.1093/cercor/bhr070.
15. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, et al,. (1997). Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 7: 191-201. (Pubitemid 27164725)
16. Crespo P, Cachero TG, Xu N, Gutkind JS, (1995). Dual effect of beta-adrenergic receptors on mitogen-activated protein kinase. Evidence for a beta gamma-dependent activation and a G alpha s-cAMP-mediated inhibition. J Biol Chem 270: 25259-25265.
17. Du G, Altshuller YM, Kim Y, Han JM, Ryu SH, Morris AJ, et al,. (2000). Dual requirement for rho and protein kinase C in direct activation of phospholipase D1 through G protein-coupled receptor signaling. Mol Biol Cell 11: 4359-4368.
18. Eggermann E, Serafin M, Bayer L, Machard D, Saint-Mleux B, Jones BE, et al,. (2001). Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 108: 177-181. (Pubitemid 33152961)
19. Ekholm ME, Johansson L, Kukkonen JP, (2007). IP(3)-independent signalling of OX(1) orexin/hypocretin receptors to Ca(2+) influx and ERK. Biochem Biophys Res Commun 353: 475-480. (Pubitemid 46014588)
20. Exton JH, (1998). Phospholipase D. Biochim Biophys Acta 1436: 105-115.
21. Fadel J, Pasumarthi R, Reznikov LR, (2005). Stimulation of cortical acetylcholine release by orexin A. Neuroscience 130: 541-547. (Pubitemid 40125492)
22. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, et al,. (1994). Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98. (Pubitemid 24179919)
23. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, Johannes FJ, (1996). Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392: 77-80. (Pubitemid 26276722)
24. Hammond SM, Altshuller YM, Sung TC, Rudge SA, Rose K, Engebrecht J, et al,. (1995). Human ADP-ribosylation factor-activated phosphatidylcholine- specific phospholipase D defines a new and highly conserved gene family. J Biol Chem 270: 29640-29643. (Pubitemid 26001622)
25. Hammond SM, Jenco JM, Nakashima S, Cadwallader K, Gu Q, Cook S, et al,. (1997). Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-alpha. J Biol Chem 272: 3860-3868.
26. Harris GC, Wimmer M, Aston-Jones G, (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437: 556-559. (Pubitemid 41613553)
27. Heinonen MV, Purhonen AK, Makela KA, Herzig KH, (2008). Functions of orexins in peripheral tissues. Acta Physiol (Oxf) 192: 471-485. (Pubitemid 351322731)
28. Hilairet S, Bouaboula M, Carriere D, Le Fur G, Casellas P, (2003). Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716. J Biol Chem 278: 23731-23737. (Pubitemid 36830197)
29. Holmqvist T, Åkerman KEO, Kukkonen JP, (2002). Orexin signaling in recombinant neuron-like cells. FEBS Lett 526: 11-14. (Pubitemid 35245683)
30. Holmqvist T, Johansson L, Östman M, Ammoun S, Åkerman KE, Kukkonen JP, (2005). OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms. J Biol Chem 280: 6570-6579. (Pubitemid 40341207)
31. Huang H, Gao Q, Peng XX, Choi S-Y, Sarma K, Ren H, et al,. (2011). piRNA-associated germline nuage formation and spermatogenesis require MitoPLD pro-fusogenic mitochondrial-surface lipid signaling. Dev Cell 20: 376-387.
32. Jenkins GM, Frohman MA, (2005). Phospholipase D: a lipid centric review. Cell Mol Life Sci 62: 2305-2316. (Pubitemid 41500546)
33. Jiang H, Luo JQ, Urano T, Frankel P, Lu Z, Foster DA, et al,. (1995). Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 378: 409-412.
34. Johansson L, Ekholm ME, Kukkonen JP, (2007). Regulation of OX(1) orexin/hypocretin receptor-coupling to phospholipase C by Ca(2+) influx. Br J Pharmacol 150: 97-104. (Pubitemid 46094674)
35. Johansson L, Ekholm ME, Kukkonen JP, (2008). Multiple phospholipase activation by OX(1) orexin/hypocretin receptors. Cell Mol Life Sci 65: 1948-1956.
36. Karteris E, Machado RJ, Chen J, Zervou S, Hillhouse EW, Randeva HS, (2005). Food deprivation differentially modulates orexin receptor expression and signalling in the rat hypothalamus and adrenal cortex. Am J Physiol Endocrinol Metab 288: E1089-E1100. (Pubitemid 40726795)
37. Khalil MB, Blais A, Figeys D, Yao Z, (2010). Lipin-the bridge between hepatic glycerolipid biosynthesis and lipoprotein metabolism. Biochim Biophys Acta 1801: 1249-1259.
38. Kim JH, Kim Y, Lee SD, Lopez I, Arnold RS, Lambeth JD, et al,. (1999). Selective activation of phospholipase D2 by unsaturated fatty acid. FEBS Lett 454: 42-46. (Pubitemid 29296922)
39. Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K, (2009). Electrophysiological effects of orexins/hypocretins on pedunculopontine tegmental neurons in rats: an in vitro study. Peptides 30: 191-209.
40. Kukkonen JP, Åkerman KEO, (2005). Intracellular signal pathways utilized by the hypocretin/orexin receptors. In:, de Lecea L, Sutcliffe JG, (eds). Hypocretins as Integrators of Physiological Signals. Springer Science; Business Media: Berlin, pp. 221-231.
41. Kukkonen JP, Holmqvist T, Ammoun S, Åkerman KE, (2002). Functions of the orexinergic/hypocretinergic system. Am J Physiol Cell Physiol 283: C1567-C1591. (Pubitemid 35340589)
42. Larsson KP, Åkerman KEO, Magga J, Uotila S, Kukkonen JP, Näsman J, et al,. (2003). Orexin-A stimulates cholecystokinin release from intestinal neuroendocrine STC-1 cells by a Ca2+-dependent mechanism. Biochem Biophys Res Commun 309: 209-216.
43. Liljedahl M, Maeda Y, Colanzi A, Ayala I, Van Lint J, Malhotra V, (2001). Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell 104: 409-420. (Pubitemid 32206461)
44. Lund PE, Shariatmadari R, Uustare A, Detheux M, Parmentier M, Kukkonen JP, et al,. (2000). The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C. J Biol Chem 275: 30806-30812.
45. Malendowicz LK, Tortorella C, Nussdorfer GG, (1999). Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J Steroid Biochem Mol Biol 70: 185-188. (Pubitemid 29528428)
46. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, et al,. (1993). Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 268: 9194-9197. (Pubitemid 23145960)
47. Morris AJ, Frohman MA, Engebrecht J, (1997). Measurement of phospholipase D activity. Anal Biochem 252: 1-9. (Pubitemid 27408684)
48. Näsman J, Bart G, Larsson K, Louhivuori L, Peltonen H, Åkerman KE, (2006). The orexin OX1 receptor regulates Ca2+ entry via diacylglycerol-activated channels in differentiated neuroblastoma cells. J Neurosci 26: 10658-10666.
49. Okumura T, Nozu T, (2011). Role of brain orexin in the pathophysiology of functional gastrointestinal disorders. J Gastroenterol Hepatol 26 (Suppl. 3): 61-66.
50. Oude Weernink PA, Han L, Jakobs KH, Schmidt M, (2007). Dynamic phospholipid signaling by G protein-coupled receptors. Biochim Biophys Acta 1768: 888-900. (Pubitemid 46452539)
51. Peltonen HM, Magga JM, Bart G, Turunen PM, Antikainen MS, Kukkonen JP, et al,. (2009). Involvement of TRPC3 channels in calcium oscillations mediated by OX(1) orexin receptors. Biochem Biophys Res Commun 385: 408-412.
52. Peltonen HM, Åkerman KE, Bart G, (2010). A role for PKD1 and PKD3 activation in modulation of calcium oscillations induced by orexin receptor 1 stimulation. Biochim Biophys Acta 1803: 1206-1212.
53. Powner DJ, Wakelam MJ, (2002). The regulation of phospholipase D by inositol phospholipids and small GTPases. FEBS Lett 531: 62-64. (Pubitemid 35232786)
54. Ramanjaneya M, Conner AC, Chen J, Kumar P, Brown JE, Johren O, et al,. (2009). Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B. J Endocrinol 202: 249-261.
55. Rey O, Papazyan R, Waldron RT, Young SH, Lippincott-Schwartz J, Jacamo R, et al,. (2006). The nuclear import of protein kinase D3 requires its catalytic activity. J Biol Chem 281: 5149-5157. (Pubitemid 43847780)
56. Rouet-Benzineb P, Rouyer-Fessard C, Jarry A, Avondo V, Pouzet C, Yanagisawa M, et al,. (2004). Orexins acting at native OX(1) receptor in colon cancer and neuroblastoma cells or at recombinant OX(1) receptor suppress cell growth by inducing apoptosis. J Biol Chem 279: 45875-45886. (Pubitemid 39491580)
57. Sarri E, Pardo R, Fensome-Green A, Cockcroft S, (2003). Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acid. Biochem J 369: 319-329. (Pubitemid 36174201)
58. Schmidt M, Voss M, Weernink PA, Wetzel J, Amano M, Kaibuchi K, et al,. (1999). A role for rho-kinase in rho-controlled phospholipase D stimulation by the m3 muscarinic acetylcholine receptor. J Biol Chem 274: 14648-14654.
59. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, et al,. (2009). Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol 5: 108-117.
60. Servitja JM, Masgrau R, Pardo R, Sarri E, von Eichel-Streiber C, Gutkind JS, et al,. (2003). Metabotropic glutamate receptors activate phospholipase D in astrocytes through a protein kinase C-dependent and Rho-independent pathway. Neuropharmacology 44: 171-180. (Pubitemid 36293256)
61. Shirai Y, Kashiwagi K, Yagi K, Sakai N, Saito N, (1998). Distinct effects of fatty acids on translocation of gamma- and epsilon-subspecies of protein kinase C. J Cell Biol 143: 511-521. (Pubitemid 28487867)
62. Soltoff SP, (2007). Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci 28: 453-458. (Pubitemid 47371266)
63. Spinazzi R, Ziolkowska A, Neri G, Nowak M, Rebuffat P, Nussdorfer GG, et al,. (2005). Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades. Int J Mol Med 15: 847-852.
64. Sung TC, Zhang Y, Morris AJ, Frohman MA, (1999). Structural analysis of human phospholipase D1. J Biol Chem 274: 3659-3666. (Pubitemid 29077210)
65. Taylor CW, Broad LM, (1998). Pharmacological analysis of intracellular Ca2+ signalling: problems and pitfalls. Trends Pharmacol Sci 19: 370-375. (Pubitemid 28458834)
66. Turunen PM, Ekholm ME, Somerharju P, Kukkonen JP, (2010). Arachidonic acid release mediated by OX(1) orexin receptors. Br J Pharmacol 159: 212-221.
67. Vasudevan A, Qian Y, Vogt A, Blaskovich MA, Ohkanda J, Sebti SM, et al,. (1999). Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I. J Med Chem 42: 1333-1340. (Pubitemid 29200868)
68. Venkatachalam K, Montell C, (2007). TRP channels. Annu Rev Biochem 76: 387-417.
69. Voisin T, El Firar A, Rouyer-Fessard C, Gratio V, Laburthe M, (2008). A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism. FASEB J 22: 1993-2002. (Pubitemid 351811475)
70. Wang X, Devaiah SP, Zhang W, Welti R, (2006). Signaling functions of phosphatidic acid. Prog Lipid Res 45: 250-278.
71. Wu M, Zaborszky L, Hajszan T, van den Pol AN, Alreja M, (2004). Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons. J Neurosci 24: 3527-3536. (Pubitemid 38481109)
72. Yamazaki M, Zhang Y, Watanabe H, Yokozeki T, Ohno S, Kaibuchi K, et al,. (1999). Interaction of the small G protein RhoA with the C terminus of human phospholipase D1. J Biol Chem 274: 6035-6038. (Pubitemid 29111004)
73. Yeaman C, Ayala MI, Wright JR, Bard F, Bossard C, Ang A, et al,. (2004). Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. Nat Cell Biol 6: 106-112. (Pubitemid 38425709)
74. Yoshida K, (2007). PKCdelta signaling: mechanisms of DNA damage response and apoptosis. Cell Signal 19: 892-901. (Pubitemid 46436445)
75. Zang R, Muller HJ, Kielbassa K, Marks F, Gschwendt M, (1994). Partial purification of a type eta protein kinase C from murine brain: separation from other protein kinase C isoenzymes and characterization. Biochem J 304: 641-647. (Pubitemid 24368249)
76. Zhang Y, Altshuller YM, Hammond SM, Hayes F, Morris AJ, Frohman MA, (1999). Loss of receptor regulation by a phospholipase D1 mutant unresponsive to protein kinase C. EMBO J 18: 6339-6348. (Pubitemid 29533238)
77. Zhao D, Frohman MA, Blusztajn JK, (2001). Generation of choline for acetylcholine synthesis by phospholipase D isoforms. BMC Neurosci 2: 16.